New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
Cristina Alexandra Ciocan-Cârtiţă, Ancuța Jurj, Lajos Ráduly, Roxana Cojocneanu, Alin Moldovan, Valentina Pileczki, Laura Pop, Liviuţa Budişan, Cornelia Braicu, Schuyler S. Korban, Ioana Berindan‐Neagoe
Topics & Concepts
Downregulation and upregulationGene silencingDoxorubicinTriple-negative breast cancerCancer researchSmall interfering RNACell growthProgrammed cell deathCellCancerBiologyTransforming growth factorBreast cancerChemistryCell cultureApoptosisTransfectionChemotherapyCell biologyGeneBiochemistryGeneticsCancer Cells and MetastasisCell Adhesion Molecules ResearchTGF-β signaling in diseases